China’s 7th High-Value Medical Consumables Procurement Includes 23 Products

This round shifts the centralized procurement focus squarely onto endoscopic and digestive-tract devices — balloon catheters, stents and guidewires — a category that had largely escaped earlier rounds dominated by cardiac and orthopedic implants. The scale is notable: 148 companies securing tentative selection across 517 products signals a crowded, fragmented field where volume-based buying could compress margins for the many smaller specialists that dominate this niche. The long runway to patient access around January 2027 gives manufacturers time to adjust, but the open question is whether this procurement model, once extended to these devices, becomes the template for other high-value categories still outside the program.